Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Blood test, Chlamydia test negative, Culture urine, Cystic fibrosis
Clinical narrative: Got vaccine during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Got vaccine during pregnancy) in a 37-year-old female patient (gravida 4, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol abuse (1/week), Placenta previa, Miscarriage on 14-Aug-2018, Congenital uterine anomaly, Bleeding, COVID-19 in May 2020, Syncope in 2011, Endometrial polyp in 2010, Pudendal neuralgia (pudenda nerve damage- rec C/S), Rosacea, Spontaneous abortion in August 2018, Irregular menstrual cycle, Pregnancy on 06-May-2019, Pregnancy on 06-Apr-2017, Polypectomy in February 2010, Cesarean section on 06-May-2019 and Cesarean section on 06-Apr-2017. Previously administered products included for Contraception: Ocp medication in 2011; for Product used for unknown indication: Spironolactone. Family history included Pancreatic cancer (father , deceased now had pancreatic cancer), Prostate cancer (Father,), Colon cancer (Paternal grandfather.), Asperger's disorder (Sister), Diabetes mellitus (Maternal uncle) and Hypertension (Mother). Concurrent medical conditions included Iodine allergy (Contrast Dye (Iodine)) and Anemia (During pregnancy). Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy, IRON from 29-Dec-2020 to an unknown date for Anemia, ANTI-D IMMUNOGLOBULIN (RHOGAM) from 29-Jan-2021 to an unknown date for Bleeding, DOCUSATE SODIUM (COLACE) from 29-Dec-2020 to an unknown date for Iron, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 29-Sep-2020 to an unknown date for Pregnancy.    On 02-Feb-2021 at 12:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 10-Oct-2020 and the estimated date of delivery was 17-Jul-2021. On 02-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Got vaccine during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixteenth week of the pregnancy. The cesarean delivery occurred on 29-Jun-2021, which was reported as Full-term. For neonate 1, the birth weight was 3175 grams (7lbs) with an APGAR score of 9 and 9 at (1, 5 minutes). The outcome was reported as Term Birth w/o Complications. Female baby, (Cesarean-REPEAT LTCS (PLACENTA PREVIA) Delivered from LOT Position, Placenta bed (R) lateral and anterior c/w acreta (Previa was mostly posterior and placenta wrapped around to the front on the right side), Placenta sent to pathology, QBL:1500cc, pregnancy complicated by : C/S x 2, Placenta Previa, possible acreta, anemia, septate  uterus, history of polyp, AMA, Rh negative. On 02-Feb-2021, EXPOSURE DURING PREGNANCY (Got vaccine during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Nov-2020, Pregnancy test: positive (Positive) Positive. On 19-Jan-2021, Smear cervix: neagtive (Negative) Negative. On 29-Jan-2021, Ultrasound scan: abnormal (abnormal) Placenta Previa was Diagnosed. On 22-Apr-2021, Diabetes mellitus: 110 (normal) 1 hour 110. On 22-Apr-2021, Glucose tolerance test: 2 hour (Inconclusive) 2 hour 1 hour  3 hour. On 22-Apr-2021, Haematocrit: 26.9% (Low) Decreased. On 22-Apr-2021, Haemoglobin abnormal: 6.8g/dl (Low) Decreased. On 22-Apr-2021, Mean cell volume: 98fl (normal) Normal. On 22-Apr-2021, Platelet count: 181 (normal) 181. On 22-Apr-2021, Rhesus antigen negative: negative (Negative) Negative. On 22-Apr-2021, Treponema test: equivocal (Inconclusive) equivocal. On 14-Jun-2021, Group B streptococcus neonatal sepsis: positive (Positive) Positive. On 23-Dec-2021, Antibody test: negative (Negative) Negative. On 23-Dec-2021, Blood test: a (normal) A. On 23-Dec-2021, Chlamydia test negative: negative (Negative) Negative. On 23-Dec-2021, Culture urine: neagtive (Negative) Negative. On 23-Dec-2021, Cystic fibrosis: negative (Negative) Negative. On 23-Dec-2021, Gonorrhoea: negative (Negative) Negative. On 23-Dec-2021, HIV antibody: non reactive (Negative) Non reactive. On 23-Dec-2021, Haematocrit: 29.5% (Low) Decreased. On 23-Dec-2021, Haemoglobin abnormal: 10.5 g/dl (Low) Decreased. On 23-Dec-2021, Haemoglobin electrophoresis: aa (Inconclusive) AA. On 23-Dec-2021, Hepatitis B surface antigen: neagtive (Negative) Negative. On 23-Dec-2021, Mean cell volume: 69 fl (Low) Decreased. On 23-Dec-2021, Platelet count: 199 (normal) 199. On 23-Dec-2021, Prenatal screening test: neg tri 13/8/21 (Inconclusive) Neg TRI. On 23-Dec-2021, Rhesus antigen negative: negative (Negative) Negative. On 23-Dec-2021, Rubella: immune (Positive) Immune. On 23-Dec-2021, Spinal muscular atrophy: negative (Negative) Negative. On 23-Dec-2021, Treponema test: non reactive (Negative) Non reactive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient previously had live full-term birth on 06-APR-2017. On 14-AUG-2018 had a miscarriage. On 06-MAY-2019 the patient had live pre-term birth and the and the child had a growth restriction for unknown reasons.  The patient's estimated date of conception was in 2020.  During the current pregnancy the patient experienced Placenta previa.  The prior history of pregnancy details were attached in the case.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Significant follow up appended from AER